Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)

SHE:001367 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Operating Revenue	502.02	470.54	396.28	421.14	386.79	283.41
Other Revenue	0.94	0.97	1.17	1.64	2.19	1.39
Revenue	502.96	471.51	397.45	422.78	388.98	284.8
Revenue Growth (YoY)	21.28%	18.63%	-5.99%	8.69%	36.58%	6.94%
Cost of Revenue	291.32	281.91	237.4	266.52	236.12	173.83
Gross Profit	211.64	189.6	160.05	156.26	152.87	110.97
Selling, General & Admin	45.14	40.65	35.72	32.25	32.94	27.19
Research & Development	33.9	27.78	18.84	15.77	12.07	10.83
Other Operating Expenses	6.57	4.36	4.16	2.13	3.11	2.59
Operating Expenses	86.58	72.88	59.15	51.24	47.85	39.97
Operating Income	125.06	116.72	100.9	105.02	105.02	71
Interest Expense	-0.36	-0.37	-0.03	-0.07	-0.1	-
Interest & Investment Income	12.89	18.41	15.62	3.55	2.25	4.22
Currency Exchange Gain (Loss)	2.37	3.32	0.87	8.37	-2.17	-3.76
Other Non Operating Income (Expenses)	-0.09	-0.24	-0.19	0.05	-0.4	-0.3
EBT Excluding Unusual Items	139.86	137.85	117.17	116.93	104.59	71.17
Gain (Loss) on Sale of Investments	-	-	-	-3.85	0.74	-
Gain (Loss) on Sale of Assets	-	-	-0.24	-	-	-
Asset Writedown	-1.21	-1.23	-0.96	-1.21	-0.67	-0.24
Other Unusual Items	6.57	5.11	4.71	11.91	3.86	2.64
Pretax Income	145.28	141.79	120.68	123.78	108.52	73.57
Income Tax Expense	19.97	19.23	16.01	16.19	14.52	10.75
Net Income	125.31	122.56	104.67	107.59	94	62.83
Net Income to Common	125.31	122.56	104.67	107.59	94	62.83
Net Income Growth	7.20%	17.09%	-2.72%	14.46%	49.62%	-8.89%
Shares Outstanding (Basic)	148	149	137	112	112	112
Shares Outstanding (Diluted)	151	150	137	112	112	112
Shares Change (YoY)	1.08%	9.35%	22.74%	-0.02%	-	-0.16%
EPS (Basic)	0.84	0.82	0.76	0.96	0.84	0.56
EPS (Diluted)	0.83	0.82	0.76	0.96	0.84	0.56
EPS Growth	6.05%	7.09%	-20.74%	14.68%	49.60%	-8.89%
Free Cash Flow	9.36	102.41	23.17	54.76	73.72	55.48
Free Cash Flow Per Share	0.06	0.68	0.17	0.49	0.66	0.50
Dividend Per Share	0.115	0.115	0.228	-	-	-
Dividend Growth	-49.65%	-49.65%	-	-	-	-
Gross Margin	42.08%	40.21%	40.27%	36.96%	39.30%	38.96%
Operating Margin	24.86%	24.75%	25.39%	24.84%	27.00%	24.93%
Profit Margin	24.92%	25.99%	26.33%	25.45%	24.16%	22.06%
Free Cash Flow Margin	1.86%	21.72%	5.83%	12.95%	18.95%	19.48%
EBITDA	141.78	131.76	113.52	118.59	117.37	81.64
EBITDA Margin	28.19%	27.94%	28.56%	28.05%	30.17%	28.67%
D&A For EBITDA	16.73	15.04	12.62	13.56	12.35	10.64
EBIT	125.06	116.72	100.9	105.02	105.02	71
EBIT Margin	24.86%	24.75%	25.39%	24.84%	27.00%	24.93%
Effective Tax Rate	13.74%	13.56%	13.26%	13.08%	13.38%	14.61%
Revenue as Reported	502.96	471.51	397.45	422.78	388.98	284.8

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.